期刊
BLOOD
卷 117, 期 1, 页码 211-220出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2010-07-298349
关键词
-
类别
资金
- Multiple Myeloma Research Foundation (MMRF)
- European Hematology Association
- Government of Navarra, Spain
- Ruth Kirschstein National Research Service Awards [T32CA070085, F32HL099177, RO1CA123204]
- Leukemia & Lymphoma Society
- Physical Sciences Oncology Center [1U54CA143869-01]
The multiple myeloma SET domain (MMSET) protein is overexpressed in multiple myeloma (MM) patients with the translocation t(4;14). Although studies have shown the involvement of MMSET/Wolf-Hirschhorn syndrome candidate 1 in development, its mode of action in the pathogenesis of MM is largely unknown. We found that MMSET is a major regulator of chromatin structure and transcription in t(4;14) MM cells. High levels of MMSET correlate with an increase in lysine 36 methylation of histone H3 and a decrease in lysine 27 methylation across the genome, leading to a more open structural state of the chromatin. Loss of MMSET expression alters adhesion properties, suppresses growth, and induces apoptosis in MM cells. Consequently, genes affected by high levels of MMSET are implicated in the p53 pathway, cell cycle regulation, and integrin signaling. Regulation of many of these genes required functional histone methyltransferase activity of MMSET. These results implicate MMSET as a major epigenetic regulator in t(4;14)+ MM. (Blood. 2011;117(1):211-220)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据